Subanaesthetic dose of esketamine during induction delays anaesthesia recovery a randomized, double-blind clinical trial

BACKGROUND: Esketamine is an antagonist of the N-methyl-D-aspartate receptor (NMDA receptor) that is widely used for multimodal analgesia. In addition to analgesia, sedation is another important effect of esketamine. However, data are limited regarding the sedation effect of esketamine during genera...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Cao, He, Jiangqin, Shi, Qinye, Bao, Fangping, Xu, Jianhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082902/
https://www.ncbi.nlm.nih.gov/pubmed/35534825
http://dx.doi.org/10.1186/s12871-022-01662-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082902/
https://www.ncbi.nlm.nih.gov/pubmed/35534825
http://dx.doi.org/10.1186/s12871-022-01662-0

Ejemplares similares